Citigroup Global Markets India Private Ltd has submitted to the Exchange a copy Pre-offer Advertisement in accordance with Regulation 18(7) and other applicable Provisions of the SEBI ( SAST) Regulations, 2011 and Subsequent amendments thereto, and Corrigendum to the detailed public shatement and the letter of offer for the attention of the shareholders of the company.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Citigroup Global Markets India, acting as the manager to a public offer, has submitted a pre-offer advertisement and a corrigendum to the detailed public statement and letter of offer to the Exchange. The filings are made under Regulation 18(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which is the standard procedure before launching an open offer to buy shares from public shareholders. A corrigendum indicates corrections or updates to the earlier published offer document. Shareholders of Sanofi Consumer Healthcare India are being addressed directly through this submission.
Shareholders should review the corrigendum carefully as it may contain revised offer price, revised dates, or corrected terms of the open offer. The submission of the pre-offer advertisement signals that the open offer process is actively progressing and shareholders may need to evaluate their participation before the offer window opens.